JBT Marel Corporation (NYSE:JBTM) Receives Average Rating of “Moderate Buy” from Brokerages

JBT Marel Corporation (NYSE:JBTM) has been assigned an average rating of “Moderate Buy” from the five brokerages that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 12 month price target among brokerages that have issued ratings on the stock in the last year is $174.6667.

Several research analysts have recently issued reports on the stock. Wall Street Zen cut shares of JBT Marel from a “buy” rating to a “hold” rating in a report on Sunday, June 21st. Weiss Ratings downgraded JBT Marel from a “hold (c+)” rating to a “hold (c)” rating in a research report on Friday, June 5th. Seaport Research Partners set a $165.00 price target on JBT Marel in a research note on Thursday, May 21st. Oppenheimer began coverage on JBT Marel in a research report on Thursday, May 21st. They set an “outperform” rating and a $175.00 price target on the stock. Finally, Zacks Research downgraded JBT Marel from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, April 28th.

JBT Marel Stock Performance

JBTM stock opened at $136.96 on Wednesday. The company has a 50-day simple moving average of $132.96 and a 200 day simple moving average of $141.37. The company has a market capitalization of $7.13 billion, a P/E ratio of 42.80, a PEG ratio of 1.46 and a beta of 0.94. The company has a quick ratio of 0.61, a current ratio of 1.01 and a debt-to-equity ratio of 0.32. JBT Marel has a fifty-two week low of $113.67 and a fifty-two week high of $170.19.

JBT Marel (NYSE:JBTM) last released its earnings results on Monday, May 4th. The company reported $1.58 EPS for the quarter, beating the consensus estimate of $1.49 by $0.09. JBT Marel had a net margin of 4.32% and a return on equity of 8.25%. The firm had revenue of $936.00 million for the quarter. During the same period in the previous year, the business posted $0.97 EPS. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. JBT Marel has set its FY 2026 guidance at 8.000-8.500 EPS. Sell-side analysts predict that JBT Marel will post 8.26 earnings per share for the current fiscal year.

JBT Marel Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 9th. Shareholders of record on Tuesday, May 26th were issued a $0.10 dividend. This represents a $0.40 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, May 26th. JBT Marel’s dividend payout ratio is presently 12.50%.

Institutional Trading of JBT Marel

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. Alliancebernstein L.P. acquired a new stake in shares of JBT Marel during the 2nd quarter valued at $135,854,000. Gildi lifeyrissjodur purchased a new stake in shares of JBT Marel during the fourth quarter valued at $170,862,000. Norges Bank purchased a new stake in shares of JBT Marel during the fourth quarter valued at $98,435,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of JBT Marel in the 2nd quarter valued at $77,963,000. Finally, P2 Capital Partners LLC acquired a new position in shares of JBT Marel in the 2nd quarter valued at $65,536,000. 98.92% of the stock is currently owned by institutional investors.

JBT Marel Company Profile

JBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market.